Pilot randomized controlled trial of a symptom cluster intervention in advanced cancer
Sharla Wells‐Di Gregorio(The Ohio State University Wexner Medical Center), Uly Magalang(The Ohio State University Wexner Medical Center), Danielle R. Probst(The Ohio State University Wexner Medical Center), William E. Carson(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Alexandra K. Zaleta(The Ohio State University Wexner Medical Center), Maryam B. Lustberg(Yale Cancer Center), Juan Peng(Central South University), David E. Cohn(The Ohio State University), Joseph P. DeCola(The Ohio State University), Don Benson(The Ohio State University), Donald R. Marks(Tufts University)
Cited by 52
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
|Molecular Biology Reports|2020|576
Psychological, Behavioral, and Immune Changes After a Psychological Intervention: A Clinical Trial
|Journal of Clinical Oncology|2004|415
Amyloid‐β associated cortical thinning in clinically normal elderly
|Annals of Neurology|2010|347